Member Log-in

I forgot my password

Not a Member? Register

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in the analysis. This analysis, which was published in Health Affairs in February, 2017, found that:

  • The poor would gain the most from immunization programs, both in terms of health gains and economic impact. One fourth of the 36 million future deaths averted by immunization would occur in the poorest 20% of the population.
  • Measles containing vaccines account for 61% of the 36 million future deaths averted.
  • Immunization would help prevent 24 million people from falling into poverty from medical impoverishment. Hepatitis B vaccine averted the largest number of medical impoverishment cases (14 million), followed by measles (5 million) and Meningitis A (3 million).

These results could be useful to immunization managers and policymakers in making the case that immunization programs have an important poverty impact, both in terms of averting a disproportionate number of deaths amongst the poorest and most vulnerable in society, and in averting future cases of poverty from medical impoverishment.

Access to the study here.

You May Also Like

LNCT Materials to Help you Make the Case for Investing in Immunization

Why We Need to Make a Case for Investment Maintaining a high performing immunization program requires sustained commitment and funding over time.  Ongoing communication and advocacy are needed to maintain investments and to stimulate additional investments to achieve health goals. Advocating for resources for immunization at national and sub-national levels requires demonstrating the health and … Continued

Teaching Vaccine Economics Everywhere (TVEE) Course Materials

1.     Health Economics for Vaccines The process of creating vaccines, manufacturing, distributing, and injecting them into individuals is a complex process requiring multiple decisions by multiple groups and individuals. On the supply side there are pharmaceutical companies, regulatory authorities, distributors, and thousands of health care workers who have to make strategic choices. On the demand side … Continued

ProVac Toolkit: Providing Tools to Support Vaccine Decision Making at Country-level

PAHO’s ProVac Initiative helps national immunization programs managers and policymakers make more robust, evidence based decisions. Since 2004, the ProVac Initiative and its collaborators have trained hundreds of people at ministries of health in the Americas and elsewhere on the development and use of vaccine impact, cost and cost-effectiveness data to inform decision making. More … Continued

Choose a Language